An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets

Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical featur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerschbaumer, Andreas, Fenzl, Karl H., Erlacher, Ludwig, Aletaha, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104808/
https://www.ncbi.nlm.nih.gov/pubmed/27822746
http://dx.doi.org/10.1007/s00508-016-1111-9
_version_ 1782466793202253824
author Kerschbaumer, Andreas
Fenzl, Karl H.
Erlacher, Ludwig
Aletaha, Daniel
author_facet Kerschbaumer, Andreas
Fenzl, Karl H.
Erlacher, Ludwig
Aletaha, Daniel
author_sort Kerschbaumer, Andreas
collection PubMed
description Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical features and comorbidities as well as current concepts of the pathophysiology and subsequent insights in novel treatment targets.
format Online
Article
Text
id pubmed-5104808
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-51048082016-12-06 An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets Kerschbaumer, Andreas Fenzl, Karl H. Erlacher, Ludwig Aletaha, Daniel Wien Klin Wochenschr Review Article Psoriatic arthritis is a chronic inflammatory joint disease occurring in a subgroup of patients suffering from psoriasis. This article gives an overview of the complexity of psoriatic arthritis, looking at several aspects of this heterogeneous disease, such as epidemiology, important clinical features and comorbidities as well as current concepts of the pathophysiology and subsequent insights in novel treatment targets. Springer Vienna 2016-11-07 2016 /pmc/articles/PMC5104808/ /pubmed/27822746 http://dx.doi.org/10.1007/s00508-016-1111-9 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Kerschbaumer, Andreas
Fenzl, Karl H.
Erlacher, Ludwig
Aletaha, Daniel
An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title_full An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title_fullStr An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title_full_unstemmed An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title_short An overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
title_sort overview of psoriatic arthritis – epidemiology, clinical features, pathophysiology and novel treatment targets
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5104808/
https://www.ncbi.nlm.nih.gov/pubmed/27822746
http://dx.doi.org/10.1007/s00508-016-1111-9
work_keys_str_mv AT kerschbaumerandreas anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT fenzlkarlh anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT erlacherludwig anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT aletahadaniel anoverviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT kerschbaumerandreas overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT fenzlkarlh overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT erlacherludwig overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets
AT aletahadaniel overviewofpsoriaticarthritisepidemiologyclinicalfeaturespathophysiologyandnoveltreatmenttargets

Ejemplares similares